FlaimSFTarkaLAFlaimKE. Binding capacity of diltiazem to myocardial beta adrenergic receptors. Clin Res1979; 27: 165A.
3.
SatoMNagaoTYamaguchiI. Pharmacological studies on a new 1,5-benzothiazepine derivative (CRD-401). I. Cardiovascular actions. Arzneim Forsch1971; 21: 1338–43.
4.
NagaoTSatoMNakajimaH. Studies on a new 1,5-benzothiazepine derivative (CRD-401). II. Vasodilator actions. Jpn J Pharmacol1972; 22: 1–10.
5.
NakajimaHHoshiyamaMYamashitaK. Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jpn J Pharmacol1975; 25: 383–92.
6.
NabataH. Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials. Jpn J Pharmacol1977; 27: 239–49.
7.
NakajimaHHoshiyamaMYamashitaK. Electrical and mechanical responses to diltiazem in potassium depolarized myocardium of the guinea pig. Jpn J Pharmacol1976; 26: 571–80.
8.
SaikawaTNagamotoYAritaM. Electrophysiologic effects of diltiazem, a new slow channel inhibitor, on canine cardiac fibers. Jpn Heart J1977; 18: 235–45.
9.
AritaMSaikawaTNagamotoY. Effects of diltiazem hydrochloride (CRD-401) on action potentials of canine heart muscle. Jpn J Clin Exp Med1975; 52: 2156.
10.
NagaoTMatlibMAFranklinD. Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. J Mol Cell Cardiol1980; 12: 29–43.
11.
WeishaarRAshikawaKBingRJ. Effect of diltiazem, a calcium antagonist, on myocardial ischemia. Am J Cardiol1979; 43: 1137–43.
12.
WeishaarREBingRJ. The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart. J Mol Cell Cardiol1980; 12: 993–1009.
13.
NakajimaHNosakaKHoshiyamaM. Effects of diltiazem on the positive inotropic and vasoconstrictor responses to ouabain in vitro. Pharmacology1977; 27: 910–4.
14.
YabeYAbeHYoshimuraS. Effect of diltiazem on coronary hemodynamics and its clinical significance. Jpn Heart J1979; 20: 83–93.
15.
TakedaKNakagawaYKatanoY. Effects of coronary vasodilators on large and small coronary arteries of dogs. Jpn Heart J1977; 18: 92–101.
16.
CaveroIBoudotJPLefevre-BorgF. Pharmacological evaluation of diltiazem and its desacetylated metabolite in several animal species: II. Hemodynamic effects of diltiazem and desacetydiltiazem in pentobarbital anesthetized dogs. In: BingRJ, ed. New drug therapy with a calcium antagonist. Diltiazem Hakone Symposium '78 (No. 487). Amsterdam: Elsevier North Holland, 1979: 71–80.
17.
NagaoTSatoMNakajimaH. Studies on a new 1,5-benzothiazepine derivative (CRD-401). IV. Coronary vasodilating effect and structure-activity relationship. Chem Pharm Bull1973; 21: 92–7.
18.
OkadaKYamaguchiYInnamiH. Effect on CRD-401, a coronary vasodilator, or systemic blood flow distribution. Jpn J Anaesth1972; 21: 781–6.
19.
SatoMMurataSNaritaH. Hypotensive effects of diltiazem hydrochloride in the normotensive, spontaneously hypertensive and renal hypertensive rats. Nippon Yakurigaku Zasshi1979; 75: 99–106.
20.
SakuraiTKuritaTNaganoS. Antihypertensive, vasodilating and sodium diuretic actions of d-cis-isomer of benzothiazepine derivative (CRD-401). Acta Urol Jpn1972; 18: 695.
21.
MoriMKoiwayaYOkamatsuS. The effects of CRD-401 on acute myocardial ischemia. Jpn Circ J1976; 40: 472–3.
22.
MillardRW. Changes in cardiac mechanics and coronary blood flow of regionally ischemic porcine myocardium induced by diltiazem. Chest1980; 78 (July suppl): 193–9.
23.
NagaoTMurataSSatoM. Effects of diltiazem (CRD-401) on developed coronary collaterals in the dog. Jpn J Pharmacol1975; 25: 281–8.
24.
FranklinDMillardRWNagaoT. Responses of coronary collateral flow and dependent myocardial mechanical function to the calcium antagonist, diltiazem. Chest1980; 78 (July suppl): 200–4.
25.
WalshRBadkeFO'RourkeR. Differential effects of diltiazem and verapamil on left ventricular performance in conscious dogs. Circulation1979; 60 (suppl II):15.
26.
WalshRBadkeFO'RourkeR. Differential effects of intracoronary calcium antagonists on regional shortening in conscious dogs. Circulation1980; 62 (suppl III):10.
27.
WalshRBadkeFO'RourkeR. Differential effects of intracoronary calcium antagonists on regional shortening in conscious dogs. Am Heart J1981; 102: 341–50.
28.
FlaimSFZelisR. Diltiazem: Systemic coronary vasodilator without negative inotropic effects on conscious rats. Fed Proc1980; 39: 2335.
29.
NakayaHSchwartzAMillardRW. Cardiac effects of equihypotensive doses of calcium channel blocking agents in conscious dogs (abstract). Circulation1981; 64: 167.
30.
IshikawaHMatsushimaAMatsuiH. Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric and femoral hemodynamics. Arzneim Forsch1978; 28: 400–2.
31.
ItoYKuriyamaHSuzukiH. The effects of diltiazem (CRD-401) on the membrane and mechanical properties of vascular smooth muscles of the rabbit. Br J Pharmacol1978; 64: 503–10.
32.
YamaguchiIIkezawaKTakadaT. Studies on a new 1,5-benzothiazepine derivative (CRD-401). VI. Effects on renal blood flow and renal function. Jpn J Pharmacol1974; 24: 511–22.
33.
TsuyusakiTNoroCYabataY. Clinical study on long term oral administration of diltiazem hydrochloride (CRD-401). Jpn J Clin Exp Med1976; 53: 247.
34.
UedaSIkegamiKSakanashiM. Effects of prostaglandin E1 on isolated dog renal artery. Urology1979; 14: 646–51.
35.
IshikawaHMatsushimaMMatsuiH. Effects of diltiazem hydrochloride (CRD-401) on renal hemodynamics of dogs. Arzneim Forsch1978; 28: 402–6.
36.
HirakawaMShiwakuYAjiT. Experimental and clinical studies on the diuretic action of CRD-401. Anesth J Resusc1975; 11: 159–62.
37.
YamaguchiIIkezawaKMurataS. Hypotensive effects of diltiazem in DOCA/saline hypertensive rats. Nippon Yakurigaku Zasshi1979; 75: 191–9.
38.
SataRTanakaSSawadaS. Vascular action of angiotensin. Effect of diltiazem (CRD) calcium antagonist on the response to angiotensin and noradrenaline in normotensive and Goldblatt-type hypertensive rats. Jpn Circ J1976; 40: 522.
39.
OsadaTKajiwaraNKobayashiY. The inhibition of hypertension and the historical changes in SHR treated with diltiazem. Jpn Heart J1979; 20: 745.
40.
OsadaTKijiwaraNKobayashiY. The inhibition of hypertension and the changes of the humoral factors in spontaneously hypertensive rat treated with diltiazem. Jpn Heart J1980; 21: 581.
41.
BushLYuk-PingLShlaferM. Protective effects of diltiazem during myocardial ischemia in isolated cat hearts. J Pharmacol Exp Ther1981; 218: 653–61.
42.
KinoshitaMTakayamaYKatoS. Protection of coronary reperfusion injury by a calcium antagonist. Jpn Circ J1980; 44: 461–6.
43.
SchwartzAGruppGMillardR. Calcium-channel blockers: Possible mechanisms of protective effects on the ischemic myocardium. Am J Physiol1982: in press.
44.
VaghyPMatlibMSzekeresL. Protective effects of verapamil and diltiazem against inorganic phosphate induced impairment of oxidative phosphorygation of isolated heart mitochondria. Biochem Pharm1981; 30: 2603–10.
45.
FlaimSFCopenhaverGLWhitesellLF. Effect of diltiazem pretreatment to reduce experimental myocardial infarct size in rat. Clin Res1980; 28: 611A.
46.
BushLRRamsonJLAshJL. Effects of diltiazem from temporary coronary artery occlusion in dogs. J Cardiovasc Pharm1982: in press.
47.
MiuraMKanazawaT. Effect of diltiazem on the infarct size in closed-chest anesthetized dogs. In: BingRJ, ed. New drug therapy with a calcium antagonist. Diltiazem Hakone Symposium '78 (No. 487). Amsterdam: Elsevier North Holland, 1979: 16–24.
48.
ClusinWTBristowMRJaillonP. Diltiazem and reduced serum ionized calcium both retard ventricular fibrillation following coronary ligation. Clin Res1981; 29: 181.
49.
SakumaMYoshikawaMSatoY. The whole body autoradiographic studies on the distribution of 14C-labeled new 1,5-benzothiazepine derivative (14D-CRD-401) in mice. Chem Pharm Bull1971; 19: 995–1005.
PiephoRWBloedowDCLaczJP. Pharmacokinetics of diltiazem in selected animal species. Am J Cardiol1982; 49: 525–8.
52.
KinneyEMoskowitzRMZelisRF. The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. J Clin Pharmacol1981; 21: 337–42.
53.
BourassaMGCotePTherouxP. Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans. Chest1980; 78 (July suppl): 224–30.
54.
YamaguchiHNagasakiFNakanishiS. Effects of diltiazem on coronary artery and hemodynamics. In: BingRJ, ed. New drug therapy with a calcium antagonist. Diltiazem Hakone Symposium '78 (No. 487). Amsterdam: Elsevier North Holland, 1979: 204–13.
55.
TabauJFCotePBourassaMG. Systemic and coronary hemodynamic effects of intravenous diltiazem in patients with coronary artery disease. Am J Cardiol1980; 45: 439.
56.
YasueHNagaoMOmoteS. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation1978; 58: 56–62.
57.
WatersDDSzlachcicJTherouxP. Ergonovine testing to detect spontaneous remission of variant angina during long-term treatment with calcium antagonist drugs. Am J Cardiol1981; 47: 179–84.
58.
HossackKFBruceRA. Divergent effects of diltiazem in patients with exertional angina. Am J Cardiol1982; 49: 538–46.
59.
RosenthalSJBaimDSLambIH. Effect of diltiazem hydrochloride capsules on cardiac hemodynamic and electrocar-diographic function. Curr Ther Res1980; 28: 319–25.
60.
DebaisieuxJCTherouxPWatersDD. Hemodynamic effects of nifedipine and diltiazem after an acute myocardial infarction. Circulation1979; 60 (suppl II):82.
61.
KinoshitaMKusukawaRShimonoY. Effects of diltiazem hydrochloride on renal hemodynamics and urinary electrolyte excretion. Jpn Circ J1978; 42: 553–60.
62.
CherrierAF. Hemodynamic effects of the association of diltiazem with beta-blockers. Data on file, Marion Laboratories, Kansas City, MO 64137.
63.
MedvedowskyJLBarnayACGauetDM. Electrophysiological study of interactions between diltiazem and propranolol, pindolol and amiodarone. Data on file, Marion Laboratories, Kansas City, MO 64137.
64.
McGrawBFGitomerSLWalkerSD. Post-marketing experience with diltiazem hydrochloride in 3913 patients (abstract). Drug Intell Clin Pharm1981; 15: 481.
65.
TakagiMTsuruhaYShiotsuH. Effect of diltiazem hydrochloride on the atrioventricular conduction. Heart1978; 10: 298.
66.
MitchelLBJutzyKRLewisSJ. Intracardiac electrophysiologic study of intravenous diltiazem and the combination of intravenous diltiazem and digoxin in man. Am Heart J1982; 103: 57–66.
67.
OyamaYImaiYNakayaH. The effects of diltiazem hydrochloride on the cardiac conduction: A clinical study of His bundle electrogram. Jpn Circ J1978; 42: 1257–64.
68.
KawaiCKonishiTMatsyamaE. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation1981; 63: 1035–42.
69.
PoolPESeagrenSCBonannoJA. The treatment of exercise-inducible chronic stable angina with diltiazem. Chest1980; 78 (July suppl): 234–8.
70.
StarlingMRCrawfordMHO'RourkeRA. Beneficial effects of diltiazem on exercise performance in patients with coronary artery disease and angina pectoris. Am J Cardiol1981; 47: 464.
71.
HossackKFBruceRA. Improved exercise performance in persons with stable angina-pectoris receiving diltiazem. Am J Cardiol1981; 47: 95–101.
72.
LowRITakedaPLeeG. Enhancement of exercise tolerance by diltiazem-induced calcium blockade in patients with coronary-artery disease. Am Heart J1981; 101: 713–8.
73.
HossackKFPoolePCrawfordM. Efficacy of diltiazem in effort angina—a multicenter study. Am J Cardiol1982; 49: 567–72.
74.
BattockDJAlverezHChidseyCA. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic activity in patients with angina pectoris. Circulation1969; 34: 157–69.
75.
DagenaisGRPittBRossRS. Exercise tolerance in patients with angina pectoris. Am J Cardiol1971; 28: 10–16.
76.
AldermanELDaviesROCrowleyJJ. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation1975; 51: 964–75.
77.
ThadaniUParkerJO. Propranolol in the treatment of angina pectoris. Circulation1979; 59: 571–9.
GionellyREGoldmanRHTriesterB. Propranolol in patients with angina pectoris. Ann Intern Med1967; 67: 1216–25.
80.
DelageFRouleanJRLabelleJ. Effects of metoprolol on effort angina during the postprandial state. Clin Pharmacol Ther1980; 27: 764–8.
81.
ThadaniUFungHDarkeAC. Oral isosorbide dinitrate in the treatment of angina pectoris. Circulation1980; 62: 491–502.
82.
GlancyDLRichterMAEllisEV. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease. Am J Med1977; 62: 39–46.
83.
StraussWEMcIntyreKMParisiAF. Safety and efficacy of diltiazem hydrochloride for stable angina pectoris. Am J Cardiol1982; 49: 560–6.
84.
DeBackerBVinckeJ. A double-blind crossover study, diltiazem versus placebo, in chronic exertional angina. Data on file, Marion Laboratories, Kansas City, MO 64137.
85.
BrechenmacherFBoxhoG. Multicenter study of diltiazem and pindolol using a double-blind crossover design. Data on file, Marion Laboratories, Kansas City, MO 64137.
86.
CanicaveJC. Double-blind crossover study of diltiazem and acebutolol using exercise testing. Data on file, Marion Laboratories, Kansas City, MO 64137.
87.
GuermonprezJLBlanchardDLancelinB. Evaluation of diltiazem in stable angina by serial exercise tests. Circulation1980; 62 (suppl III):296.
88.
KoberGBerladTHopfR. The effect of diltiazem and nifedipine on exercise-induced ST-segment depression and heart rate in patients with coronary heart disease. Z Kardiol1981; 70: 59–65.
89.
KoiwayaY. The effects of diltiazem hydrochloride on hemodynamics, epicardial unipolar ECG and regional myocardial blood flow in dogs with acute coronary occlusion. Fukuoka Igaku Zasshi1980; 71 (2):61–83.
90.
KasaharaKTsuchiyaYSawatoS. Clinical effect of CRD-401 on angina pectoris—an evaluation by double-blind technique. Diagn Treat1975; 63: 696.
91.
MizunoYYasuiSTobataI. Effect of CRD-401 on ischemic heart diseases. Jpn J Clin Exp Med1973; 50: 565.
92.
StraussWEMcIntyreKMParisiAF. Short and long-term efficacy and safety of diltiazem HCl in treatment of propranolol resistant stable angina. Clin Res1981; 29: 244.
93.
PepineCJFeldmanRLWhittleJ. Effect of diltiazem in patients with variant angina: A randomized double-blind trial. Am Heart J1981; 101: 719–25.
94.
RosenthalSJGinsburgRLambIH. Efficacy of diltiazem for control of symptoms of coronary arterial spasm. Am J Cardiol1980; 46: 1027–32.
95.
SchroederJSFeldmanRLGilesTD. Multiclinic controlled trial of diltiazem for Prinzmetal's angina. Am J Med1982: in press.
96.
YasueH. Effects of diltiazem on angina pectoris in comparison with other antianginal drugs. In: BingRJ, New drug therapy with a calcium antagonist. Diltiazem Hakone Symposium '78 (No. 487). Amsterdam: Elsevier North Holland, 1979: 219–27.
97.
KimuraEKishidaH. Treatment of variant angina with drugs: A survey of 11 cardiology institutes in Japan. Circulation1981; 63: 844–8.
98.
YasueH. Pathophysiology and treatment of coronary arterial spasm. Chest1980; 78 (July suppl): 216–23.
99.
YasueHOmoteSMatsushitaN. Response of angina at rest to various drugs. Jpn Circ J1976; 40: 472.
100.
YasueHOmoteSNagaoM. Angina decubitus: Responses of angina at rest to various drugs. Mod Med1976; 31: 2201.
101.
YasueHOmoteSTakizawaA. Pathogenesis and treatment of angina pectoris at rest as seen from its response to various drugs. Jpn Circ J1978; 42: 1–10.
102.
YasueHOmoteSTakizawaA. Exertional angina pectoris caused by coronary arterial spasm: Effects of various drugs. Am J Cardiol1979; 43: 647–52.
103.
YasueHOmoteSTakizawaA. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: Role of exercise-induced coronary arterial spasm. Circulation1979; 59: 938–48.
104.
WatersDDTherouxPSzlachcicJ. Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina. Am J Cardiol1981; 48: 123–30.
105.
CassagnesJLamaisonDPalcouxMC. Treatment of unstable angina by diltiazem. Therapie1980; 35: 465–73.
106.
AoiWSuzukiSDoiY. Clinical use of diltiazem hydrochloride (Herbesser) in hypertension. Clin Rep1978; 12: 3589.
107.
IkedaM. Double-blind studies on diltiazem in essential hypertensive patients receiving thiazide therapy. In: BingRJ, ed. New drug therapy with a calcium antagonist. Diltiazem Hakone Symposium '78 (No. 487). Amsterdam: Elsevier North Holland, 1979: 243–53.
108.
IkedaMAokiKArakawaR. Clinical effect of diltiazem (Herbesser) on essential hypertension; comparison with placebo by double-blind method. Med Progr1979; 110: 302.
109.
KatsunumaHKoyamaTIshigakiY. The effect of diltiazem hydrochloride (Herbesser) on hypertension. Med Consult New Remed1977; 14: 761.
110.
KawaiYYamamotoTOgamiT. Clinical effect of diltiazem hydrochloride in hypertension. J Adult Dis1975; 5: 1495–502.
111.
KusabaT. The hypotensive effect of Herbesser in essential hypertension. Mod Clin Med1978; 20: 1859.
112.
MaedaKTakasugiTTuskanoY. Clinical study of the hypotensive effect of diltiazem hydrochloride. Int J Clin Pharmacol Ther Toxicol1981; 19: 47–55.
113.
MueSTakishimaT. Clinical use of Herbesser in essential hypertension; special reference to cases complicated with bronchial asthma. Mod Clin Med1978; 20: 2029.
114.
OhtaT. Long-term observation on clinical hypotensive effect of diltiazem hydrochloride. Clin Rep1978; 12: 2833.
115.
SakaiK. Long-term Herbesser therapy in hypertension. Mod Clin Med1978; 20: 1053.
116.
TakaharaM. Hypotensive effect of diltiazem hydrochloride on essential hypertension. Clin Rep1978; 12: 1993.
117.
TojoSShishidoHYamamotoS. Effects of CRD-401 on blood pressure and renal function. Jpn J Clin Exp Med1972; 49: 1958.
118.
YorifujiSKawaiYAramiS. Hypotensive effect of diltiazem hydrochloride (Herbesser tablets) in patients with essential hypertension. J Adult Dis1979; 9: 893–907.
119.
IkedaMOginoKKanekoY. Clinical effect of diltiazem on essential hypertension. Comparison with propranolol in thiazide combination therapy by double-blind group comparison test. Clin Rep: In press.
120.
VouhePRHeliasJGrondinCM. Myocardial protection through cold cardioplegia using diltiazem, a calcium channel blocker. Ann Thorac Surg1980; 30: 342–8.